AI Molar Mind to help people quit smoking with oral health feedback
Official title: the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation: Randomized Control Trial
Run by Fayoum University · NCT06762210 · Data updated 2026-11-12
This study will test whether AI Molar Mind, a digital tool that reviews your oral health and gives personalized feedback, can help adults who smoke at least five cigarettes a day quit smoking.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Fayoum University Academic / other |
| Locations | 1 site (Fayoum, Alexandria Governorate) |
| Status | Recruiting |
| Started | February 12, 2026 |
| Main results expected | May 2026 |
| Study ends | September 2026 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT06762210 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 who smoke ≥5 cigarettes per day, are motivated to quit, and have access to a smartphone or computer are ideal candidates.
✕Probably not a fit
People who are pregnant, have severe psychiatric conditions, or are already using other smoking cessation therapies may not receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–65 who smoke at least five cigarettes per day and are motivated to quit will use AI Molar Mind on a smartphone or computer to receive automated oral health evaluations and personalized feedback intended to motivate quitting. Pregnant people, individuals with severe psychiatric conditions, and those already using other cessation therapies are excluded. The intervention is delivered through the Faculty of Dentistry at Fayoum University and outcomes will track smoking cessation and changes in oral health over the follow-up period.
Why it matters
Potential benefit: If successful, this tool could boost quit rates by using visible, personalized oral health feedback to motivate behavioral change.
How similar studies have gone: Digital and AI-based cessation tools have shown promise in prior studies, but using dental health evaluations as the main motivator is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18-65 years * smoke ≥5 cigarettes per day * motivated to quit smoking, * have access to a smartphone or computer Exclusion Criteria: * Pregnant women * individuals with severe psychiatric conditions * those already using other smoking cessation therapies.
Where it's running
-
faculty of Dentistry, Fayoum University
Fayoum, Alexandria Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Alshaimaa Mohamed, PhD — Fayoum University
- Study coordinator: Alshaimaa shabaan, PhD
- Email: aas16@fayoum.edu.eg
- Phone: 00201006047940
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
A program to help people quit smoking using CBT and mindfulness audio support
This study is testing if combining text messages for quitting smoking with mindfulness audio support helps people stop smoking better than just using text messages alone.
-
Smoking cessation for parents with health navigator support to tackle social needs
We’re testing a program that helps parents quit smoking and also addresses their social challenges to reduce kids’ exposure to secondhand smoke.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Volitional Help Sheets to Support Smoking Cessation in Clinical Care
This pilot tests whether adding a short, personalized if-then planning tool helps people in a French clinic quit smoking when used alongside usual care.
-
Nicotine Orodispersible Tablet to Relieve Cravings in Smokers
A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.